GLOBUS MEDICAL, INC. Restructuring Costs
GLOBUS MEDICAL, INC. (GMED) reported Restructuring Costs of $1.96 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2026-08-06
- GLOBUS MEDICAL, INC. restructuring costs for the quarter ending 2026-06-30 was $1.96M, a 85.55% decline year-over-year.
- GLOBUS MEDICAL, INC. restructuring costs for the quarter ending 2026-03-31 was $5.21M.
- GLOBUS MEDICAL, INC. restructuring costs for the quarter ending 2025-12-31 was $1.14M, a 16242.86% increase year-over-year.
- GLOBUS MEDICAL, INC. restructuring costs for the quarter ending 2025-09-30 was $358.00K, a 93.10% decline year-over-year.
- GLOBUS MEDICAL, INC. restructuring costs for fiscal 2025 was $15.05M, a 36.70% decline from fiscal 2024.
- GLOBUS MEDICAL, INC. restructuring costs for fiscal 2024 was $23.77M.
- GLOBUS MEDICAL, INC. restructuring costs for fiscal 2023 was $0.00.
| Period end | Restructuring Costs 3 month | Restructuring Costs 6 month | Restructuring Costs 9 month | Restructuring Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.96M 10-Q · filed 2026-08-06 | $7.17M 10-Q · filed 2026-08-06 | $8.31M derived: sum of 3 quarters · filed 2026-08-06 | $8.67M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $5.21M 10-Q · filed 2026-05-07 | $6.36M derived: sum of 2 quarters · filed 2026-05-07 | $6.71M derived: sum of 3 quarters · filed 2026-05-07 | $20.26M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.50M derived: sum of 2 quarters · filed 2026-02-24 | $15.05M derived: sum of 3 quarters · filed 2026-08-06 | $15.05M 10-K · filed 2026-02-24 |
| 2025-09-30 | $358.00K 10-Q · filed 2025-11-06 | $13.90M derived: sum of 2 quarters · filed 2026-08-06 | $13.90M 10-Q · filed 2025-11-06 | $13.91M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $13.55M 10-Q · filed 2026-08-06 | $13.55M 10-Q · filed 2026-08-06 | $13.55M derived: sum of 3 quarters · filed 2026-08-06 | $18.75M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | $7.00K derived: sum of 2 quarters · filed 2026-05-07 | $5.20M derived: sum of 3 quarters · filed 2026-05-07 | $4.63M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $5.20M derived: sum of 2 quarters · filed 2026-02-24 | $4.63M derived: sum of 3 quarters · filed 2026-02-24 | $23.77M 10-K · filed 2026-02-24 |
| 2024-09-30 | $5.19M 10-Q · filed 2025-11-06 | $4.63M derived: sum of 2 quarters · filed 2025-11-06 | $23.77M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | -$566.00K 10-Q · filed 2025-08-07 | $18.57M 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $19.14M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |